Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
10/14/1999 | CA2327885A1 Methods and apparatus for the conditioning of cartilage replacement tissue |
10/13/1999 | EP0949330A2 Lactobacilli strains having inhibitory and/or microbicidal activity against pathogenic microorganisms and a method for inducing and keeping said activity in lactobacilli cultures |
10/13/1999 | EP0948963A1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
10/13/1999 | EP0948621A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions |
10/13/1999 | EP0948594A1 Method and device for microinjection of macromolecules into non-adherent cells |
10/13/1999 | EP0948348A1 Manipulation of non-terminally differentiated cells using the notch pathway |
10/13/1999 | EP0948346A1 USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS |
10/13/1999 | EP0948338A1 Utilization of an egg-based preparation as an antidepressant |
10/13/1999 | EP0948337A1 Treatment of hemoglobin containing erythrocytes with nitric oxide |
10/13/1999 | EP0948266A1 Ubiquinone-containing, non-alcoholic beverage |
10/13/1999 | CN1231674A Use of proteins as anti-retroviral agents |
10/13/1999 | CN1231203A Ointment for rheumatic spur |
10/13/1999 | CN1231201A Compound donkey-hide gelatin preparation for preventing arrest of bone marrow in chemotherapy and radiotherapy and preparing process thereof |
10/13/1999 | CN1231196A Capsule for promoting male sexual function and preparation process |
10/13/1999 | CN1231194A Capsule for treating pointed condyloma and preparation process |
10/13/1999 | CN1231183A Method for preparing medicine for growing leukocyte by Chinese silkworm production gene engineering |
10/13/1999 | CN1231182A Bear gallbladder injection |
10/13/1999 | CN1231181A New usage for Ganmaotong (Common cold medicine) |
10/13/1999 | CN1231136A Cow placenta health care foods and production method |
10/13/1999 | CN1231131A Insects protein capsule or powder medicine and preparation process thereof |
10/13/1999 | CN1045538C Natural composition oral medicine for treating male sterility |
10/13/1999 | CN1045537C Traditional Chinese medicinal pillfor curing gonorrhea and preparation process thereof |
10/13/1999 | CN1045536C Plaster for curing fracture |
10/13/1999 | CN1045535C Xifengdingjian pill preparation process capable of calming endopathic wind alleviating epilepsy |
10/12/1999 | US5965596 Providing an amount of beta-alanine to blood to increase beta-alanylhistidine dipeptide synthesis in the human tissue, simultaneous accumulation of creatine within a tissue |
10/12/1999 | US5965535 Isolated human leukocyte antigen (hla) class ii-binding peptide and amino sequence encoding it; the peptides stimulate the activity and proliferation of cd4+ t lymphocytes |
10/12/1999 | US5965436 Method of isolating mesenchymal stem cells associated with isolated megakaryocytes by isolating megakaryocytes |
10/12/1999 | US5965435 Genetically engineered genes containing the herpes virus of turkeys gc gene, thymidine kinase region of marek's disease virus, infectious laryngotracheitis virus's open reading frame and ribonucleotide reductase genes; for vaccines |
10/12/1999 | US5965404 Adding nucleic acid/polycation complexes to animal cells in presence of ethylene glycol and/or glycerol; for simple and accurate transfection of cells for gene therapy and tumor vaccine production |
10/12/1999 | US5965349 Methods of photodecontamination using synthetic media |
10/12/1999 | US5965151 Bioactive concentrate, its producing method and certain drug compositions containing also chondroitin sulphate |
10/12/1999 | US5965129 Purified cathepsin polypeptide and amino acid sequence or immunologically active fragments thereof; administering the novel protein with a pharmaceutical carrier to treat cancer |
10/12/1999 | US5965128 Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli |
10/12/1999 | US5964805 Method and paste for articular cartilage transplantation |
10/07/1999 | WO1999050413A2 THERAPEUTIC APPLICATIONS OF MATURE FLINT (mFLINT) POLYPEPTIDES OR OPG3, A MEMBER OF THE TNF RECEPTOR SUPERFAMILY |
10/07/1999 | WO1999050403A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses |
10/07/1999 | WO1999050394A1 Suppressive monocyte derived cells, process for their preparation and their uses in pharmaceutical compositions |
10/07/1999 | WO1999050393A2 Use of stimulated peripheral blood mononuclear cells for the treatment of brain-related diseases, disorders and damage |
10/07/1999 | WO1999050392A1 Methods and compositions for eliciting an immune response to a telomerase antigen |
10/07/1999 | WO1999050391A1 Stimulated monocyte derived cells, their preparation and uses |
10/07/1999 | WO1999050285A2 Production methods and uses of a retrovirus |
10/07/1999 | WO1999050266A1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents |
10/07/1999 | WO1999049977A1 A carrier for holding a flexible fluid processing container |
10/07/1999 | WO1999049898A1 Progression elevated gene-3 and uses thereof |
10/07/1999 | WO1999049897A1 Hemoglobin-polysaccharide conjugates |
10/07/1999 | WO1999049881A2 Application of hsp70 proteins |
10/07/1999 | WO1999049877A2 Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions |
10/07/1999 | WO1999049876A2 Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof |
10/07/1999 | WO1999049875A1 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients |
10/07/1999 | WO1999049734A1 Method of inhibiting immune system destruction of transplanted viable cells |
10/07/1999 | WO1999027924A3 Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals |
10/07/1999 | DE19814701A1 Verwendung von stimulierten mononukleären Zellen des peripheren Blutes zur Behandlung von mit dem Gehirn assoziierten Erkrankungen, Störungen und Schädigungen Use of stimulated peripheral blood mononuclear cells for the treatment of brain-related diseases, disorders and injuries |
10/07/1999 | DE19813760A1 Activation of natural killer cells to stimulate immune response, especially in treatment of tumors, infections and autoimmune diseases |
10/07/1999 | CA2347067A1 Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer |
10/07/1999 | CA2325735A1 Hsp70 protein for the treatment of tumours, cancer or infectious diseases through nk-cell activation |
10/07/1999 | CA2324517A1 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily |
10/07/1999 | CA2324441A1 Materials and methods relating to a novel retrovirus |
10/07/1999 | CA2324421A1 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses |
10/07/1999 | CA2320491A1 Stimulated monocyte derived cells, their preparation and uses |
10/07/1999 | CA2291780A1 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients |
10/07/1999 | CA2290363A1 Method of inhibiting immune system destruction of transplanted viable cells |
10/06/1999 | EP0947578A1 Substance with antiobestic and cumulative visceral fat-reducing actions and use thereof |
10/06/1999 | EP0946733A1 Hsv/aav hybrid amplicon vectors |
10/06/1999 | EP0946724A2 POLYPEPTIDES OF THE "BASIC-HELIX-LOOP-HELIX" bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES |
10/06/1999 | EP0946713A1 Method for in vitro preconditioning of myoblasts before transplantation |
10/06/1999 | EP0946710A1 Methods of preserving prokaryotic cells and compositions obtained thereby |
10/06/1999 | EP0946199A1 TGF beta 1-RESPONSIVE CELLS FROM BONE MARROW |
10/06/1999 | EP0946186A1 Stomach submucosa derived tissue graft |
10/06/1999 | EP0820349B1 Centrifugal system for spillover collection of sparse components such as mononuclear cells |
10/06/1999 | CN1230989A Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
10/06/1999 | CN1230967A Process for producing plasma protein-containing medicament |
10/06/1999 | CN1230421A Chinese medicine preparation for curing residual jaundice of viral hepatitis |
10/06/1999 | CN1230420A Psoriasis treating Chinese medicine preparation and its preparing process |
10/06/1999 | CN1230415A Combined Chinese and Western medicine for treating nevus and its preparation |
10/06/1999 | CN1230414A Medicine for preventing cerebral thrombus |
10/06/1999 | CN1230413A Medicine for preventing hypertension cerebral hemorrhage |
10/06/1999 | CN1230411A Benificial bifidolactic acid substance |
10/06/1999 | CN1230370A Chlorophyte tortoise extraction liquid and its use |
10/06/1999 | CN1045389C Healthy medicine and its medicine bag for external use |
10/06/1999 | CN1045385C Lactagogue |
10/05/1999 | USRE36331 Use of L-carnitine and alkanoyl L-carnitines in the storage of blood for transfusions and stabilizing solutions containing them |
10/05/1999 | US5962653 Methods of obtaining antiviral proteins and antiviral peptides from Nostoc ellipsosporum |
10/05/1999 | US5962650 Oxygen-reduced aqueous solution of factor VIII |
10/05/1999 | US5962644 Porcine CD34 |
10/05/1999 | US5962420 Wound healing agents; drug delivery; crosslinking fibrin |
10/05/1999 | US5962411 Human growth hormone variants and methods of administering same |
10/05/1999 | US5962331 Cell growth regulator |
10/05/1999 | US5962325 Three-dimensional stromal tissue cultures |
10/05/1999 | US5962257 Flea aminopeptidase nucleic acid molecules |
10/05/1999 | US5962217 MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof |
10/05/1999 | US5962026 Solid compositions of fibrin monomer |
10/05/1999 | US5961972 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity |
10/05/1999 | CA2161962C Adenovirus vectors for gene therapy |
09/30/1999 | WO1999049030A1 Compounds related to pap-1 |
09/30/1999 | WO1999049027A1 Methods for prevention and treatment of cancer |
09/30/1999 | WO1999049015A2 Cardiac-derived stem cells |
09/30/1999 | WO1999049014A1 Localization and propagation of neural and neuronal progenitor cells |
09/30/1999 | WO1999048524A1 Use of cytokines and mitogens to inhibit graft versus host disease |
09/30/1999 | WO1999048510A1 Immunoglobulin m antibody production inhibitor and anti-rheumatoid arthritis drug |
09/30/1999 | WO1999048507A2 Steroidal saponins for treating alzheimer's disease |